• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥氮平从脂质微球中的双模式释放。

Bimodal release of olanzapine from lipid microspheres.

机构信息

Department SMETEC, University of Bologna, Bologna, Italy.

出版信息

J Pharm Sci. 2010 Oct;99(10):4251-60. doi: 10.1002/jps.22146.

DOI:10.1002/jps.22146
PMID:20737632
Abstract

Olanzapine was formulated as 10% (w/w) mixture with cutina to which stearic acid was added, ranging from 10% to 90% (w/w) of the total mass to control the drug release. The molten mixtures were processed by ultrasound-assisted spray-congealing technique, obtaining solid microspheres. The drug is stable under these conditions and only a partial miscibility in the solid state was observed by DSC between the two fatty materials with two separated melting endotherms in the thermograms: this can be due to the presence of two phases inside the solid dispersion. Olanzapine is distributed into the two phases according to its partition coefficient: two phases make the system less suitable to crystallization of the drug; the loading of the drug could reach saturation with difficulty and the rate of the olanzapine release is differentiated, since the drug is released from two different carriers. Dissolution profiles suggest occurrence of a bimodal release, where each portion of the release profile is linear and the slope increases with a higher content of stearic acid in the carrier mixture, that behaves as a release promoter. Tests were also carried out with palmitic and lauric acids for comparison and also for systems in the absence of ultrasound.

摘要

奥氮平被配制成 10%(重量/重量)与角质的混合物,其中加入了从 10%到 90%(重量/重量)的硬脂酸,以控制药物释放。熔融混合物通过超声辅助喷雾凝固技术进行处理,得到固体微球。在这些条件下,药物是稳定的,只有通过 DSC 在两种脂肪材料之间观察到部分混溶性,在热谱图中有两个单独的熔融吸热峰:这可能是由于固分散体内部存在两个相。奥氮平根据其分配系数分布在两个相中:两个相使系统不太适合药物结晶;药物的负载很难达到饱和,并且药物的释放速率也不同,因为药物是从两种不同的载体中释放出来的。溶解曲线表明存在双峰释放,其中释放曲线的每个部分都是线性的,斜率随着载体混合物中硬脂酸含量的增加而增加,硬脂酸作为释放促进剂。还进行了棕榈酸和月桂酸的测试进行比较,也进行了没有超声的系统的测试。

相似文献

1
Bimodal release of olanzapine from lipid microspheres.奥氮平从脂质微球中的双模式释放。
J Pharm Sci. 2010 Oct;99(10):4251-60. doi: 10.1002/jps.22146.
2
Image analysis of lutrol/gelucire/olanzapine microspheres prepared by ultrasound-assisted spray congealing.超声辅助喷雾冷凝法制备的 Lutrol/ 泊洛沙姆/奥氮平微球的图像分析
Eur J Pharm Biopharm. 2014 Nov;88(3):909-18. doi: 10.1016/j.ejpb.2014.08.014. Epub 2014 Sep 11.
3
Diclofenac salts, part 6: release from lipid microspheres.双氯芬酸盐,第 6 部分:从脂微球中释放。
J Pharm Sci. 2011 Aug;100(8):3482-3494. doi: 10.1002/jps.22581. Epub 2011 Apr 26.
4
Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.脂质基质对载奥氮平固体脂质纳米粒的药物包封率、体外释放及物理稳定性影响的研究
AAPS PharmSciTech. 2007 Oct 12;8(4):E83. doi: 10.1208/pt0804083.
5
Determination of solid state characteristics of spray-congealed Ibuprofen solid lipid microparticles and their impact on sustaining drug release.喷雾冷凝法制备的布洛芬固体脂质微粒的固态特性测定及其对药物缓释的影响
Mol Pharm. 2015 May 4;12(5):1592-604. doi: 10.1021/acs.molpharmaceut.5b00015. Epub 2015 Apr 15.
6
Olanzapine solvates.奥氮平溶剂化物。
J Pharm Sci. 2013 Nov;102(11):4046-56. doi: 10.1002/jps.23714. Epub 2013 Aug 20.
7
Thermal behaviour and stability in Olanzapine.奥氮平的热行为与稳定性
Int J Pharm. 2005 Sep 14;301(1-2):33-40. doi: 10.1016/j.ijpharm.2005.05.035.
8
Influence of the composition of glycerides on the solid-state behaviour and the dissolution profiles of solid lipid extrudates.甘油酯组成对固体脂质挤出物的固态行为和溶解曲线的影响。
Int J Pharm. 2009 Nov 3;381(2):184-91. doi: 10.1016/j.ijpharm.2009.03.002. Epub 2009 Mar 19.
9
An investigation into the mechanisms of drug release from taste-masking fatty acid microspheres.掩味脂肪酸微球药物释放机制的研究
J Pharm Sci. 2008 Sep;97(9):3842-54. doi: 10.1002/jps.21243.
10
Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.吲哚美辛/PVP固体分散体肠溶微粒的拉曼光谱与热分析
Eur J Pharm Biopharm. 2008 Sep;70(1):409-20. doi: 10.1016/j.ejpb.2008.03.016. Epub 2008 Apr 8.

引用本文的文献

1
In Situ Co-Amorphization of Olanzapine in the Matrix and on the Coat of Pellets.奥氮平在微丸基质及包衣层中的原位共无定形化
Pharmaceutics. 2022 Nov 24;14(12):2587. doi: 10.3390/pharmaceutics14122587.
2
Enhanced Dissolution and Oral Bioavailability of Piroxicam Formulations: Modulating Effect of Phospholipids.吡罗昔康制剂的溶出度和口服生物利用度增强:磷脂的调节作用
Pharmaceutics. 2010 Oct 27;2(4):339-350. doi: 10.3390/pharmaceutics2040339.
3
Influence of Hydroxypropyl Methylcellulose on Metronidazole Crystallinity in Spray-Congealed Polyethylene Glycol Microparticles and Its Impact with Various Additives on Metronidazole Release.
羟丙基甲基纤维素对喷雾冷冻聚乙二醇微粒中甲硝唑结晶度的影响及其与各种添加剂对甲硝唑释放的影响。
AAPS PharmSciTech. 2015 Dec;16(6):1357-67. doi: 10.1208/s12249-015-0320-2. Epub 2015 May 2.